Plasmapheresis and related techniques: What should we know

Journal Medical Libanais

Volumn 50, Issue 1-2, 2002, Pages 45-49

  Mallat, Samir G ^a   Ismail, Nuhad ^b  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b Hôtel Dieu de France ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DISEASE; BLOOD VISCOSITY; GUILLAIN BARRE SYNDROME; HUMAN; KIDNEY DISEASE; MICROANGIOPATHY; MUSHROOM POISONING; MYASTHENIA GRAVIS; PARAQUAT POISONING; PLASMA TRANSFUSION; PLASMAPHERESIS; REVIEW;

BLOOD COMPONENT REMOVAL; HUMANS; IMMUNOGLOBULINS; PLASMA EXCHANGE; PLASMAPHERESIS;

EID: 0043240425     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Leitman SF, Kucero E, McLeod B et al. Guidelines for Therapeutic Hemaphoresis. Bethesda, MD: American Association of Blood Banks, 1992.
2. Baarth WF, Wocher D, Waldmann TA, Fahey JL. Metabolism of human gamma macroglobulins. J Clin Invest 1964; 3: 1036-48.
3. Cohen S, Freeman T. Metabolic heterogeneity of human gamma globulin. Biochem J 1960; 76: 475-87.
4. Kaplan AA. Toward the rational prescription of therapeutic plasma exchange the kinetics of immunoglobulin removal. Seminars in Dialysis 1992; 5 (3): 227-9.
5. Hakim RM. Plasmapheresis. In: The Principles and Practice of Nephrology. Jacobson HR, Striker GE, and Klahr SK (eds). Second edition. Mosby-Yearbook Inc. 1995: 713-21.
6. Sowada K, Malchesky PS, Nose Y. Available removal systems: State of the art. In: Therapeutic Hemaphoresis in the 1990s. Nydegger UE (ed). Curr Stud Hematol Blood Transf Basel Karger, 1990; 57: 51-113.
7. Price CA, Mc Carley PB. Technical considerations of therapeutic plasma exchange as a nephrology nursing procedure. ANNA J 1993; 20: 41-6.
8. Sutton DMC, Nair RC, Rock G, and the Canadian Apheresis Study Group. Complications of plasma exchange. Transfusion 1989; 29: 124-7.
9. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 1994; 23 (6): 817-27.
10. Kale Pradhan PB, Pramodini B, Woo MH. A review of the effects of plasmaphoresis on drug clearance. Pharmacotherapy 1997; 17 (4): 684-95.
11. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 1996; 7: 367-86.
12. Kaplan AA. Plasma exchange in renal disease. Seminars in Dialysis 1996; 9 (1); 61-70.
13. Johnson JP, Moore JJ, Austin HB, Balow JE, Antonovych TT, Wilson CB. Therapy of antiglomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985; 64: 219-27.
14. Simpson IJ, Doak PB, Williams LC et al. Plasma exchange in Goodpasture's syndrome. Am J Nephrol 1982; 2: 301-11.
15. Dawson RB, Brown JA, Mahalati K et al. Durable remissions following prolonged plasma exchange in thrombotic thrombocytopenia purpura. J Clin Apheresis 1994; 9: 112-15.
16. Ferri C, Moriconi L, Gremignai G et al. Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephrol 1985; 43: 246-53.
17. Singer DR, Venning MC, Lockwood CM, Pusey CD. Cryoglobulinemia: Clinical features and response to treatment. Ann Med Intern 1986; 137: 251-3.
18. Sinico RA, Fornasieri A, Fiorini G et al. Plasma exchange in the treatment of essential mixed cryoglobulinemia nephropathy. Long term follow-up. Int J Artif Organs 1985; 2: 15-18.
19. Siami G, Siami F, Fergusson P, Stone WJ, Zorowski M. Cryofiltration apheresis for treatment of cryoglobulinemia associated with hepatitis C. ASAIO Journal 1995; 41: M315-M318.
20. Cole E, Cattran D, Magil AA et al. A prospective randomized trial of plasma exchange as additive in idiopathic crescentic glomerulonephritis. Am J Kidney Dis 1992; 20 (3): 266-9.
21. Rifle G, Dechelette E. Treatment of rapidly progresssive glomerulonephritis by plasma exchange and methylprednisolone pulses. A prospective randomized trial of cyclophosphamide. Interim analysis. The French Cooperative Group. Prog Clin Biol Res 1990; 337: 263-7.
22. Artero ML, Sharma R, Savin VJ, Vincenti F. Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 1994: 23: 574-81.
23. Frampton G, Cameron JS, Thom M, Jones SS, Raftery M. Successful removal of antiphospholipid antibody during pregnancy using plasma exchange and low dose prednisolone. Lancet 1987; 2: 1023-4.
24. Hene RJ, Kater L. Plasmaphoresis in nephritis associated with Henoch Shonlein Purpura and in primary IgA nephropathy. Plasma Ther Transfus Technol 1983; 4: 165-73.
25. Coppo R, Basolo B, Roccatello D, Piccoli G. Plasma exchange in primary IgA nephropathy and Henoch Schonlein syndrome. Plasma Ther Transfus Technol 1985; 6: 705-23.
26. Dau PC, Denys EH. Plasmaphoresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome. Ann Neurol 1982; 11: 570-5.
27. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffman RG. Chronic progresssive multiple sclerosis: Double blind controlled study of plasmaphoresis in patients taking immunosuppressive drugs. Neurol 1985; 35: 312-19.
28. The Canadian Cooperative Multiple Sclerosis Study Group: The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. Lancet 1991; 337: 441-6.
29. Bussel JB, Saal S, Gordon B. Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfus 1988; 28: 38-41.
30. Bernstein ML, Schneider BK, Naiman JL. Plasma exchange in refractory acute auto immune hemolytic anemia. J Pediatr 1981; 98: 774-5.
31. Martin JN, Files JC, Blake PG, Perry KG Jr, Morrisson JC, Norman PH. Post partum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets). Am J Obstet Gynecol 1995; 172: 1107-25.
32. Anonymous, Plasmaphoresis and acute Guillain Barré syndrome. Guillain Barré Syndrome Study Group. Neurology 1985; 35: 1096-104.
33. Dyck PJ, Daube J, O'Brien P et al. Plasma exchange in chronic inflammatory demyelinating polyneuropathy (abstract). Ann Neurol 1983; 14: 122.
34. Seybold ME. Plasmaphoresis in myasthenia gravis. Ann NY Acad Science 1987; 505: 584-7.
35. Dyck PJ, Low PA, Windebank AJ et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991; 325: 1482-6.
36. lsbister JP, Biggs JC, Penny R. Experience with large volume plasmaphoresis in malignant paraproteinemia and immune disorders. Aust N ZJ Med 1978; 8: 154-64.
37. Slocombe GW, Newland AC, Colvin MP, Colvin BT. The role of intensive plasma exchange in the prevention and management of hemorrhage in patients with inhibitors to Factor VIII. B J Haematol 1981; 47: 577-85.
38. Bosch T. State of the art of lipid aphoresis. Artificial Organs 1996; 20 (4): 292-5.
39. Seidel D. HELP aphoresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs 1996; 20: 303-10.
40. Malchesky PS et al. Thermofiltration in hypercholesterolemia treatment. J Clin Aphoresis 1990; 5: 145-50.
41. Nydegger UE. Therapeutic hemaphoresis in 1990's, by Krager, 1990.
42. Snyder HW Jr, Cochran SK, Balint JP Jr et al. Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood 1992; 79 (9): 2237-45.
43. Stegmayr B, Tamvik A. Complement activation in plasma exchange by single filtration and centrifugation and in cascade filtration. Blood Purif 1989: 7 (1): 10-15.
44. Tani T, Hanasawa K, Endo Y et al. Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymixin B immobilized column. Artif Organs 1998; 22: 1038-44.